179 related articles for article (PubMed ID: 21990014)
21. Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties.
Ouellet C; Maltais R; Ouellet É; Barbeau X; Lagüe P; Poirier D
Eur J Med Chem; 2016 Aug; 119():169-82. PubMed ID: 27155470
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy.
Purohit A; Chander SK; Woo LW; Parsons MF; Jhalli R; Potter BV; Reed MJ
Anticancer Res; 2008; 28(3A):1517-23. PubMed ID: 18630506
[TBL] [Abstract][Full Text] [Related]
23. 4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatase.
Nussbaumer P; Bilban M; Billich A
Bioorg Med Chem Lett; 2002 Aug; 12(16):2093-5. PubMed ID: 12127511
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of N-acylated tyramine sulfamates containing C-F bonds as steroid sulfatase inhibitors.
Daśko M; Rachon J; Masłyk M; Kubiński K; Demkowicz S
Chem Biol Drug Des; 2017 Jul; 90(1):156-161. PubMed ID: 28032462
[TBL] [Abstract][Full Text] [Related]
25. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
Daśko M; Przybyłowska M; Rachon J; Masłyk M; Kubiński K; Misiak M; Składanowski A; Demkowicz S
Eur J Med Chem; 2017 Mar; 128():79-87. PubMed ID: 28152429
[TBL] [Abstract][Full Text] [Related]
27. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
[TBL] [Abstract][Full Text] [Related]
28. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816
[TBL] [Abstract][Full Text] [Related]
29. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and structure-activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate.
Woo LW; Wood PM; Bubert C; Thomas MP; Purohit A; Potter BV
ChemMedChem; 2013 May; 8(5):779-99. PubMed ID: 23495205
[TBL] [Abstract][Full Text] [Related]
31. Lead optimization of 4-(thio)-chromenone 6-
R S; Mk K
J Recept Signal Transduct Res; 2021 Apr; 41(2):123-137. PubMed ID: 32705921
[TBL] [Abstract][Full Text] [Related]
32. Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Winiski AP; Billich A
J Med Chem; 2003 Nov; 46(23):5091-4. PubMed ID: 14584960
[TBL] [Abstract][Full Text] [Related]
33. Steroid sulfatase inhibitors: a review covering the promising 2000-2010 decade.
Maltais R; Poirier D
Steroids; 2011; 76(10-11):929-48. PubMed ID: 21458474
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
Foster PA; Chander SK; Parsons MF; Newman SP; Woo LW; Potter BV; Reed MJ; Purohit A
Breast Cancer Res Treat; 2008 Sep; 111(1):129-38. PubMed ID: 17914670
[TBL] [Abstract][Full Text] [Related]
35. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
Thomas MP; Potter BV
J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
[TBL] [Abstract][Full Text] [Related]
36. C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors.
Ganeshapillai D; Woo LWL; Thomas MP; Purohit A; Potter BVL
ACS Omega; 2018 Sep; 3(9):10748-10772. PubMed ID: 30320251
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of bicoumarin thiophosphate derivatives as steroid sulfatase inhibitors.
Demkowicz S; Kozak W; Daśko M; Masłyk M; Gielniewski B; Rachon J
Eur J Med Chem; 2015 Aug; 101():358-66. PubMed ID: 26163883
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.
Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857
[TBL] [Abstract][Full Text] [Related]
39. New potent STS inhibitors based on fluorinated 4-(1-phenyl-1
Daśko M; Demkowicz S; Rachon J; Biernacki K; Aszyk J; Kozak W; Masłyk M; Kubiński K
J Asian Nat Prod Res; 2020 Nov; 22(11):1037-1044. PubMed ID: 31773975
[TBL] [Abstract][Full Text] [Related]
40. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.
Reed JE; Woo LW; Robinson JJ; Leblond B; Leese MP; Purohit A; Reed MJ; Potter BV
Biochem Biophys Res Commun; 2004 Apr; 317(1):169-75. PubMed ID: 15047163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
